PSMD13 expression in lung adenocarcinoma strongly correlates with PSMC6 expression, which is associated with poor tumor differentiation and might act as a therapeutic target in lung adenocarcinoma (Zhang et al., 2021). The gene discussed is PSMD13; the disease is neoplasm.